ArticleCancer immunology research2026

In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy.

Mitra Shourian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.